Cargando…

Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure

AIMS: Renal dysfunction (RD) is associated with increased morbidity and mortality in heart failure (HF). At present, no specific treatment for patients with RD, to prevent progression of HF, has been developed. How different hormone axes—and thereby potential treatment options—are affected by RD in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosselmann, Helle, Tonder, Niels, Sölétormos, György, Gaborit, Freja, Rossing, Kasper, Iversen, Kasper, Goetze, Jens Peter, Gustafsson, Finn, Schou, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695175/ https://www.ncbi.nlm.nih.gov/pubmed/29154425 http://dx.doi.org/10.1002/ehf2.12186

Ejemplares similares

Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure
por: Stoltze Gaborit, Freja, et al.
Publicado: (2016)

Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure
por: Gaborit, F, et al.
Publicado: (2015)

Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study
por: Gaborit, Freja Stoltze, et al.
Publicado: (2020)

Routine biomarkers are strong predictors of short term mortality
por: Kristensen, Michael, et al.
Publicado: (2015)

Routine biomarkers are strong predictors of short term mortality
por: Kristensen, Michael, et al.
Publicado: (2015)

Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study
por: Gaborit, Freja Stoltze, et al.
Publicado: (2019)

Prevalence of airflow obstruction in patients with stable systolic heart failure
por: Dalsgaard, Morten, et al.
Publicado: (2017)

Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction
por: Rossing, Kasper, et al.
Publicado: (2016)

Aortic Pulsatility Index: A New Haemodynamic Measure with Prognostic Value in Advanced Heart Failure
por: Deis, Tania, et al.
Publicado: (2022)

Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)
por: Parveen, Saaima, et al.
Publicado: (2022)

Routine blood tests are associated with short term mortality and can improve emergency department triage: a cohort study of >12,000 patients
por: Kristensen, Michael, et al.
Publicado: (2017)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Comparison of systematic triage with clinical assessment in prediction of short-term mortality
por: S Iversen, Anne K, et al.
Publicado: (2015)

Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide study
por: Jensen, Jesper, et al.
Publicado: (2023)

Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2019)

The formation and design of the TRIAGE study - baseline data on 6005 consecutive patients admitted to hospital from the emergency department
por: Plesner, Louis Lind, et al.
Publicado: (2015)

Aldosterone Contributes to Vasopressin Escape through Changes in Water and Urea Transport
por: Wang, Yanhua, et al.
Publicado: (2023)

Aldosterone and vasopressin affect α- and γ-ENaC mRNA translation
por: Perlewitz, Andrea, et al.
Publicado: (2010)

Aldosterone Decreases Vasopressin-Stimulated Water Reabsorption in Rat Inner Medullary Collecting Ducts
por: Wang, Yanhua, et al.
Publicado: (2020)

Vasopressin receptors V1(a) and V2 are not osmosensors
por: Lykke, Kasper, et al.
Publicado: (2015)

Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudy
por: Winsløw, Ulrik, et al.
Publicado: (2023)

Predictors of right ventricular function as measured by tricuspid annular plane systolic excursion in heart failure
por: Kjaergaard, Jesper, et al.
Publicado: (2009)

One‐Year Mortality After Intensification of Outpatient Diuretic Therapy
por: Madelaire, Christian, et al.
Publicado: (2020)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve
por: Holmager, Pernille, et al.
Publicado: (2017)

Mitigating risk of aldosterone in diabetic kidney disease
por: Frimodt-Møller, Marie, et al.
Publicado: (2020)

Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008)

ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial
por: Brandt-Jacobsen, Niels, et al.
Publicado: (2022)

Phosphorylation of CaMK and CREB-Mediated Cardiac Aldosterone Synthesis Induced by Arginine Vasopressin in Rats with Myocardial Infarction
por: Zhai, Yuan-Sheng, et al.
Publicado: (2022)

Expression of vasopressin mRNA in the hypothalamus of individuals with a diagnosis of schizophrenia
por: Busch, Johannes R., et al.
Publicado: (2019)

Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function
por: Puar, Troy H., et al.
Publicado: (2022)

Vasopressin and methylprednisolone for in-hospital cardiac arrest — Protocol for a randomized, double-blind, placebo-controlled trial
por: Andersen, Lars W., et al.
Publicado: (2021)

ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study
por: Lauridsen, Bo K, et al.
Publicado: (2013)

Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study
por: Axelsson Raja, Anna, et al.
Publicado: (2020)

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)
por: Jürgens, Mikkel, et al.
Publicado: (2019)

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
por: Jürgens, Mikkel, et al.
Publicado: (2021)

Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer
por: Kristiansen, Søren, et al.
Publicado: (2015)

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
por: Brandt‐Jacobsen, Niels H., et al.
Publicado: (2023)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Regulation of urinary calcium excretion by vasopressin
por: Anastasio, Pietro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qtjikdhaip49031pake477ssk